n-(3-(aminomethyl)benzyl)acetamidine has been researched along with T-Cell Lymphoma in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, H | 1 |
| Vishwamitra, D | 1 |
| Curry, CV | 1 |
| Manshouri, R | 1 |
| Diao, L | 1 |
| Khan, A | 1 |
| Amin, HM | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and T-Cell Lymphoma
| Article | Year |
|---|---|
NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Gene Expression Regu | 2013 |